We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues Advice for Complex Generic Applicants on Meeting Requests
FDA Issues Advice for Complex Generic Applicants on Meeting Requests
The FDA has published final guidance detailing ways for sponsors of complex generic drug products to improve their discussions with the agency, offering recommendations for requesting and conducting drug development meetings, pre-submission meetings and mid-review-cycle meetings.